Canadian recommendations for clinical trials of pharmacologic interventions in rheumatoid arthritis: Inclusion criteria and study design
Review
Overview
MeSH Major
Arthritis, Rheumatoid
Clinical Trials as Topic
Patient Selection
Research Design
abstract
There is an urgent need to modify clinical trial inclusion criteria and other study design features to better reflect the current characteristics of people living with RA in the countries where the new drugs will be used.
